title: P2Y12 inhibitors in acute coronary syndromes: how do we choose the best drug for our patients?
authors: Steen D
authors: SD
authors: Kristensen
authors: Erik L
authors: EL
authors: Grove
authors: Anne-Mette
authors: AM
authors: Hvas
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D000077144:Clopidogrel; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D010879:Piperazines / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D000068799:Prasugrel Hydrochloride; D013876:Thiophenes / Q000008:administration & dosage*; D000077486:Ticagrelor; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine